Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion into Taiwan further underscores the Company’s accelerating global adoption and ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Microarray technology encompasses a few relatively well-established methods and numerous applications that are in various stages of development. Apart from their use as a tool for diagnostic testing ...

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...

Well, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPreptm Library Prep Kit, the newest addition to its next-generation TnXtm transposase ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.